Tampa, FL, United States of America

Donald L Herber

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Bausch-Lomb Incorporated. Active years: 2017.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Donald L. Herber

Introduction

Donald L. Herber is a notable inventor based in Tampa, FL (US). He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of suspensions of low-solubility materials. His work has implications for the development of effective drug formulations.

Latest Patents

Donald L. Herber holds a patent for a method of preparing suspensions of low-solubility materials. This process involves producing a pharmaceutical suspension that includes an active pharmaceutical ingredient (API) with low solubility. The method consists of preparing a first solution with a carboxy-containing vinyl polymer and a solvent, followed by adding the API compound under high-shear mixing conditions. This innovative approach results in a suspension where the concentration of the API exceeds its solubility in the solvent, enhancing the effectiveness of the pharmaceutical formulation. He has 1 patent to his name.

Career Highlights

Herber is associated with Bausch + Lomb Incorporated, a company renowned for its advancements in eye health products. His work at Bausch + Lomb has allowed him to focus on innovative solutions that address challenges in pharmaceutical formulations.

Collaborations

Throughout his career, Donald L. Herber has collaborated with esteemed colleagues, including Daniel J. Stein and Steven K. MacLeod. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Donald L. Herber's contributions to the pharmaceutical industry through his innovative patent demonstrate his commitment to improving drug formulations. His work continues to influence the field and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…